Anchyra Partners Llc
Source: SEC Form 13F · as of Mar 2026Anchyra Partners Llc holds 23 biotech & pharma companies tracked by BioSniper, totaling $15.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$15.1M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 2,297 | $2.1M |
| JNJJOHNSON & JOHNSON | 6,358 | $1.6M |
| ABBVAbbVie Inc. | 5,399 | $1.2M |
| UTHRUNITED THERAPEUTICS Corp | 1,952 | $1.2M |
| MRKMerck & Co., Inc. | 9,211 | $1.1M |
| AMGNAMGEN INC | 2,990 | $1.1M |
| MCKMcKesson Corporation | 1,174 | $1.0M |
| NVSNovartis AG | 4,170 | $637K |
| AZNASTRAZENECA PLC | 3,001 | $592K |
| WSTWest Pharmaceutical Services Inc. | 2,224 | $557K |
| PMPhilip Morris International Inc | 2,875 | $475K |
| GILDGILEAD SCIENCES, INC. | 3,242 | $452K |
| BMYBRISTOL MYERS SQUIBB CO | 6,929 | $420K |
| IQVIQVIA Holdings Inc. | 2,446 | $417K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,372 | $371K |
| PFEPFIZER INC | 11,889 | $334K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 5,504 | $304K |
| ABTABBOTT LABORATORIES | 2,922 | $300K |
| REGNREGENERON PHARMACEUTICALS, INC. | 381 | $294K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 602 | $269K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 12,466 | $231K |
| NVONovo Nordisk A/S | 6,106 | $224K |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 18,043 | $14K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.